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osting by EAbstract Two simple, rapid, sensitive, low-cost, and accurate methods (A and B) for the microde-
termination of amantadine HCl (AMD) in pure form and in pharmaceutical formulations are devel-
oped. Method A is based on the formation of tris (o-phenanthroline)-iron(II) complex (ferroin)
upon reaction of amantadine HCl with an iron (III)-o-phenanthroline mixture in sodium acetate-
acetic acid buffer media. The ferroin complex is spectrophotometrically measured at kmax 509 nm
against reagent blank. Method B is based on the reduction of Fe (III) by the drug which forms col-
ored complex (kmax 521 nm) with 2,20-bipyridyl. Optimizations of the experimental conditions are
described. Beer’s law is obeyed in the concentration ranges 0.4–10 and 0.6–22 lg mL1 using
1,10-phenanthroline and 2,20-bipyridyl, respectively. The developed methods have been successfully
applied for the determination of AMD in bulk drugs and in pharmaceutical formulations. The com-
mon excipients and additives did not interfere in their determinations.
ª 2010 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Amantadine HCl chemically as 1-adamantanamine hydrochlo-
ride, or known formally as 1-aminoadamantane hydrochloride.0133391366.
o.com (H.A. Omara).
y. Production and hosting by
Saud University.
lsevierThe molecule consists of adamantane backbone that is substi-
tuted at one of the four methyne positions with an amino group.
This compound is sold under the name ‘‘Symmetrel’’ for use
both as an antiviral and an antiparkinsonian drug, againstAsian
inﬂuenza and eventually received approval for the treatment of
Inﬂuenza virusA (Moiseev et al., 1976;Maugh, 1979;Hounshell
and Smith, 1988) in adults, issued an alert to doctors not to pre-
scribe amantadine any more for the season. Among some Asian
countries, A/H3N2 and A/H1N1 resistance has reached 100%
(Varough et al., 2007). Amantadine hydrochloride (AMD),
Scheme 1, is an antiviral agent used against infection with
inﬂuenza typeAvirus and to ameliorate symptomswhen admin-
istered during the early stages of infection as well as in the man-
agement of herpes zoster (Prud’homme et al., 1997). It has mild
anti-Parkinsonism activity and thus it has been used in the man-
agement of Parkinsonism, mainly in the early disease stage and
Scheme 1 Amantadine hydrochloride (AMD).
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the hydrochloride salt (Martindale, 2002).
Spectrophotometry is considered as the most convenient
analytical technique in pharmaceutical analysis because of its
inherent simplicity and availability in most quality control
and clinical laboratories (Amin et al., 2009, 2008). However,
AMD does not possess any chromophore in its molecule, which
are the essential requirements for the direct analysis by spectro-
photometric techniques. Therefore, derivatization of AMDwas
necessary for its determination. For spectrophotometric deter-
mination of AMD, it has been derivatized with different re-
agents. The involved derivatization reactions that have been
published prior to 1983 have been reviewed (Kirschbaum,
1983). The derivatizing reagents used thereafter included iodine
(Darwish et al., 2006), acetaldehyde/chloranil (Darwish et al.,
2006), a,a-diphenyl-b-picrylhydrazyl (Salman and Bayrakdur,
1983), bromocresol green (Sultan, 2004), tetracyanoethylene
(Rizk et al., 2003), iron(III) (Mustafa et al., 2004), and cyclo-
dextrin, Kuwabara et al., 1999). As well, many derivatization
techniques coupled with chromatography have been estab-
lished for the determination of AMD in the dosage forms
and biological matrices: TLC (Askal et al., 2008), HPLC
(Duh et al., 2005; Higashi et al., 2006), GC (Leis et al., 2002),
and capillary electrophoresis (Reichova´ et al., 2002).
Redox reactions have been used as the basis for the devel-
opment of simple and sensitive spectrophotometric methods
for the determination of many pharmaceutical compounds
(Amin et al., 2003; Shama et al., 2006, 2009; El-Didamoony
et al., 2006). For these reasons, these reactions were attempted
for use in the present study. In oxidimetric reactions, the most
commonly used oxidizing agents is Fe(III) whish reduced to
Fe(II), and then determined with either 1,10-phenanthroline
or 2,20-bipyridyl. None of these reagents have not been previ-
ously used for the spectrophotmetric analysis of amantadine
HCl. For these reasons, the present study was dedicated to
investigate the application of these reagents in the spectropho-
tometric analysis of AMD in their pharmaceutical dosage
forms and spiked plasma samples. The proposed methods
were used for quality control analysis, where modern and
expensive apparatus such as GLC, HPLC and HPTLC are
not available.2. Experimental
2.1. Apparatus
All the spectral measurements were made using either Perkin–
Elemer Lambda 12 and Perkin–Elemer 73B spectrophotome-
ters, with scanning speed 400 nm/min and band width 2.0 nm,equipped with 10 mm matched quartz cells and a Metrohm
(Switzerland) pH-meter were used for spectrophotometric pH
measurements. A thermostat water bath, JOUAN, J18 Bain
Universal (France) was used to carry out the temperature
studies.
2.2. Material and reagents
All chemicals used were of analytical grade and all solutions
were freshly prepared in doubly distilled water.
(1) Pure amantadine HCl bulk powder was obtained from
Egyptian Organization for Control and Pharmaceutical
Research – Egypt. Amantadine HCl working solution
prepared by dissolving 0.01 g of pure AMD in 50 mL
of bidistilled water and complete to 100 ml with bidis-
tilled water to obtain the working standard solution of
concentration 100 lg mL1.
(2) Preparation of Fe(III)-o-phenanthroline reagent (Mahrous,
1991). Mix 0.198 g of 1,10-phenanthroline monohydrate
(Fluka, Swiss) with 2.0 mL of 1.0 M HCl and 0.16 g of
ferric ammonium sulphate dodecahydrate (Fluka, Swiss)
and dilute with bidistilled water to 100 mL.
(3) Preparation of Fe(III)-bipyridyl reagent ( Mahrous,
1991) (Hapkin & Williams, England), dissolve 0.16 g
of 2,20-bipyridyl in 2.0 mL of 1.0 M HCl and 0.16 g of
ferric ammonium sulphate dodecahydrate.
(4) Acetate buffer solutions were prepared as recommended
previously (Britton, 1952).2.3. General procedure for bulk powder
Aliquots (0.03–1.0 mL) and (0.06–2.2 mL) of 100 lg mL1
AMD standard solution were transferred for Methods A and
B, respectively, into a series of 10 mL calibrated ﬂasks;
1.6 mL Fe3+-o-phen (Method A) or 1.1 mL Fe3+-bipy (Meth-
od B) reagent solution and 2.0 mL of pH 4.3 (method A) or
3.0 mL of pH 4.16 (method B) acetate buffer solution were
added and heated on a water bath at 70 C for 10 min. The
mixture was cooled to room temperature (25 ± 1 C), and
the volume was diluted to the mark with double-distilled
water. The colored complexes formed were measured at 509
and 521 nm for methods A and B, respectively, against a
reagent blank treated similarly.
2.4. Capsules sample solution
Twenty capsules were carefully evacuated; their contents were
weighed and ﬁnely powdered. An accurately weighed quantity
of the capsule contents equivalent to 100 mg of AMD was
transferred into a 100 mL calibrated ﬂask, and dissolved in
about 40 mL of distilled water. The contents of the ﬂask were
swirled, sonicated for 5.0 min, and then completed to volume
with water. The contents were mixed well and ﬁltered rejecting
the ﬁrst portion of the ﬁltrate. The prepared solution was di-
luted quantitatively with distilled water to obtain a suitable
concentration for the analysis.
2.5. Spiked plasma samples
Aliquots of 1.0 mL of plasma were spiked with different con-
centration levels of AMD. The spiked plasma samples were
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Figure 2 Effect of ml added of acetate buffer on absorbance of
6.0 lg mL1 of AMD for method A (phen.) and 10.0 lg mL1 for
method B (bipy.).
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1.0 min. The samples were centrifuged for 20 min at
13000 rpm. The supernatants were transferred into test tubes
and neutralized with 1.0 M NaOH solution.
3. Results and discussion
Ferric salts play a prominent role in the spectrophotometric
determination of many pharmaceutical drugs, acting as an oxi-
dant, a ferric salt gets reduced to ferrous salt and this amount
corresponds to drug concentration. The amount of Fe(II) can
be determined using selective reagents such as 1,10-phenan-
throline and 2,20-bipyridyl. These properties have been utilized
to develop a spectrophotometric methods for the determina-
tion of AMD. 1,10-phenanthroline and 2,20-bipyridyl are
organic bases with similar chemical structure and contain the
iron (II) speciﬁc group (Marczenko, 1976).
The proposed methods A and B are based on the formation
of tris (o-phenanthroline) or tris(2,2-bipyridyl)-iron(II) chelate
upon the reaction of AMD with an iron (III)-o-phenanthroline
or iron (III)-2,20-bipyridyl reagent. The reaction proceeds
through reduction of iron(III) ions to iron(II) and subsequent
formation of the intensive orange-red colored complex.
The absorption spectra of the colored complexes in the pro-
posed methods showed a characteristic kmax values as in
(Fig. 1). The experimental conditions were established by vary-
ing each parameter individually (Massart et al., 1988).
3.1. Effect of pH
An acetate buffer solution was optimal among those examined
(universal, phosphate, thiel, borate, and acetate). pH adjust-
ment is necessary, especially in acidic medium, because the
reaction was affected by change of pH in the range of
(2.5–5.6). The optimum pH value was 4.3 for method A, and
4.14 is the optimum for method B. Moreover, 2.0 mL buffer
solution was sufﬁcient for method A, whereas 3.0 mL is the
best for method B, for complete color development (Fig. 2).
3.2. Effect of reagent concentration
The addition of 1.6 mL of Fe3+-o-phen or 1.1 mL of Fe3+-bipy
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Figure 1 Absorption spectra for the colored comples of 6.0 lg
mL1 of AMD for method A (phen.) and 10.0 lg mL1 for
method B (bipy.).absorbance for the studied complexes. Smaller amounts gave
incomplete complex formation. A larger concentration had
no effect on complex formation, although the absorbance in-
creased slightly due to the background of the reagent used.3.3. Effect of temperature and heating time
The effects of temperature and heating time on the formation
of the colored complexes were studied. The reaction of AMD
with both reagents proceeds very slowly at room temperature.
Higher temperature was used to accelerate the reaction. Max-
imum absorbance was obtained after heating for about 10 min
with both Fe2+-phen and Fe2+-bipy colored complexes on a
water bath at 70 C. At lower temperature, the rate of color
development becomes progressively slower. Further heating
caused no appreciable change in the color. The obtained com-
plex was stable for more than 48 h.3.4. Validation of the proposed methods
3.4.1. Calibration curves, linearity and sensitivity
Under the optimum reaction conditions described above, the
calibration curves for AMD using the proposed methods em-
ployed in the present work were constructed. The regression
equations for the results were derived using the least squares
method. In all cases, Beer’s law plots (n= 6) were linear with
very small intercepts and good correlation coefﬁcients in the
general concentration range of 0.4–10.0 and 0.6–22.0 lg mL1,
using method A and B, respectively (Table 1). For more accu-
rate analysis, Ringbom optimum concentration range were
evaluated to be 0.7–9.60 and 1.0–21.2 lg mL1, respectively
(Table 1).
Statistical analysis of the results obtained (Table 1), indi-
cated that the proposed methods were accurate and precise.
The limits of detection (LOD) and limits of quantitation
(LOQ) were determined (Irving et al., 1981) using the formula:
LOD or LOQ ¼ jSDa=b;
where j= 3 for LOD and 10 for LOQ, SDa is the standard
deviation of the intercept, and b is the slope. Based on the basis
of six replicate measurements, the limits of detection were 0.12,
and 0.18 lg mL1 and the limits of quantiﬁcation were 0.39,
Table 1 Analytical characteristics of the proposed methods.
Parameter Methods
Fe2+-phen Fe2+-bipy
pH (acetate buﬀer) 4.30 4.16
kmax (nm) 509 521
Stability/h 48 48
Beer’s conc. range (lg mL1) 0.4–10.0 0.6–22.0
Ringbom optimum range (lg mL1) 0.7–9.6 1.0–21.2
Detection limits (ng mL1) 0.12 0.58
Quantiﬁcation limits (lg mL1) 0.39 0.373
Molar absorptivity (L mol1 cm1) 1.92 · 104 0.91 · 104
Sandell sensitivity (ng cm2) 9.8 20.7
Regression equationa
Slope 0.1023 0.0483
RSD% of slope 0.0091 0.0063
Intercept 0.0081 0.0018
Correlation coeﬃcient 0.9996 0.9994
RSD% 1.09 1.18
Range of error% ±1.20 ±1.00
Calculated t-values (2.57)b 1.07 0.76
Calculated F-test (5.05)b 2.47 2.03
a A = a+ bC, where C is the concentration in lg mL1.
b Values in parentheses are the theoretical values for t- and F-
values at 95% conﬁdence limits and ﬁve degrees of freedom.
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LOD and LOQ values conﬁrmed the sensitivity of the pro-
posed methods.
3.4.2. Precision
The precision of the methods (within-assay and between-
assays) were determined at the AMD concentrations cited in
Table 2. The within-assay precision was assessed by analyzing
six replicates of each sample as a batch in a single assay run,
and the between-assays precision was assessed by analyzing
the same sample, as triplicate, in two separate assay runs.
The relative standard deviations (RSD) were less than 1.2%
(Table 2). This level of precision was adequate for the quality
control analysis of AMD.Table 2 Precision of the proposed methods for analysis of AMD (
Method Taken (lg mL1) Within-assays
Mean (lg mL1 ± SD)
Fe2+-phen 1.5 1.51 ± 0.49
3.0 2.97 ± 0.34
4.5 4.48 ± 0.50
6.0 6.03 ± 0.47
7.5 7.48 ± 0.37
9.0 9.89 ± 0.41
Fe2+-Bipy 4.0 4.06 ± 0.32
8.0 8.10 ± 0.33
12.0 11.88 ± 0.27
16.0 15.90 ± 0.43
20.0 20.88 ± 0.45
22.0 21.80 ± 0.99
SD, standard deviations; RSD, relative standard deviations.3.4.3. Speciﬁcity and interference
The proposed spectrophotometric methods have the advanta-
ges that the measurements are performed in the visible region,
away from the UV-absorbing interfering substances that might
be co-extracted from AMD containing dosage forms. Regard-
ing the interference of the excipients and additives usually pre-
sented in pharmaceutical formulation (sodium lauryl sulfate,
magnesium stearate, starch sodium glycolate, lactose spray
dried, carboxymethylcellulose PA 102, talc, titanium dioxide,
microcrystalline cellulose, hydroxypropylcellulose and prege-
lanitizated starch), their is no interference indicating the high
selectivity of the proposed methods and applicability to use
for routine determination in pure and in dosage forms.
3.4.4. Ruggedness and robustness
The ruggedness of the proposed methods was assessed by
applying the procedures using two different instruments in
two different laboratories at different elapsed time. Results ob-
tained from lab-to-lab and day-to-day variation was found to
be reproducible as RSD did not exceed 1.18%. Robustness of
the methods was assessed by evaluating the inﬂuence of small
variation of experimental variables: concentrations reagent,
buffer, temperature and reaction time, on the analytical perfor-
mance of the method. In these experiments, one experimental
parameter was changed while the other parameters were kept
unchanged, and the recovery percentage was calculated each
time. The small variations in any of the variables did not
signiﬁcantly affect the results; recovery percentages were
99.2–100.67, and 99.6–101.4% for methods A and B, respec-
tively. This provided an indication for the reliability of the pro-
posed methods during routine work.
3.5. Applications
3.5.1. Analysis of dosage forms
The obtained satisfactory validation results made the proposed
methods suitable for the routine quality control analysis of
AMD and its dosage forms pharmaceutical formulations
(Amantine, Amantadine, and Viraﬂu capsules). The results ob-
tained by the proposed methods were statistically compared
with those obtained by the ofﬁcial pharmacopoeia methodn= 6).
Between-assays
RSD% Mean (lg mL1 ± SD) RSD%
0.84 1.49 ± 0.76 0.88
0.68 3.03 ± 0.45 0.65
0.88 4.51 ± 0.43 0.92
0.87 5.89 ± 0.59 0.95
0.74 7.61 ± 0.47 0.78
1.09 9.11 ± 0.37 1.14
0.45 4.05 ± 0.46 0.54
0.68 7.95 ± 0.54 0.74
0.59 1.21 ± 0.41 0.63
0.83 2.39 ± 0.36 0.87
0.94 3.21 ± 0.31 0.91
1.18 22.05 ± 0.87 1.05
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dium hydroxide. Each milliliter of 0.1 M sodium hydroxide is
equivalent to 18.77 mg of AMD). The obtained mean values of
the labeled amounts ranged from 99.80 ± 0.80, and
99.5 ± 0.7%, using A, and B methods, respectively as re-
corded in Table 3. In the t- and F-tests, no signiﬁcant differ-
ences were found between the calculated and theoretical
values of both the proposed and the reported methods at
95% conﬁdence level (Miller and Miller, 1993). This indicated
similar precision and accuracy in the analysis of AMD in its
formulations. It is evident from these results that all the pro-
posed methods are applicable to the analysis of AMD in its
capsules with comparable analytical performance. However,
the critical recommendations of these methods might be based
on the experimental conditions and the ultimate sensitivity that
determines the amount of specimen required for analysis. For
example, the method involving Fe2+-phen is recommended
whenever sensitive analysis is required; this because they have
very high sensitivity.Table 3 Determination of AMD in capsules (100 mg/capsule)
and spiked plasma by the proposed and ofﬁcial method (BP,
2007).
Parameter Fe2+-phen Fe2+-bipy Oﬃcial
Amantine capsulec
Recovery%a 100.2 ± 1.2 100.4 ± 1.2 99.6 ± 1.8
±Standard deviation 0.76 0.84 1.20
Number of experiments 6 6 6
Variance 0.81 0.89 1.11
t-testb 1.13 0.98
F-valueb 2.62 2.43
Amantadin capsuled
Recovery%a 99.6 ± 0.8 99.4 ± 1.2 99.6 ± 0.7
±Standard deviation 0.88 0.96 0.74
Number of experiments 6 6 6
Variance 0.98 1.08 1.27
t-testb 0.76 0.9
F-valueb 1.57 2.43
Viraﬂu capsulee
Recovery%a 99.8 ± 1.0 99.5 ± 0.7 100 ±1.2
±Standard deviation 0.91 1.11 1.25
Number of experiments 6 6 6
Variance 1.13 1.25 1.42
t-testb 0.88 1.17
F-valueb 2.12 2.35
Spiked plasma pimples
Mean recovery%a 99.5 ± 0.8 99.2 ± 1.0 100.3 ± 1.5
±Standard deviation 1.11 0.92 1.32
Number of experiments 6 6 6
Variance 1.02 0.78 1.23
t-testb 1.37 1.19
F-valueb 2.88 2.71
a Average values of six determinations were used for the ofﬁcial
and the proposed methods, respectively.
b Theoretical values for t and F at 95% conﬁdence limit are 2.57
and 5.05, respectively.
c Memphis Pharmaceutical & Chemicals Industries Company,
Cairo, Egypt.
d Misr Pharmaceutical Industries Company, Cairo, Egypt.
e Sigma Pharmaceutical Industries Company, El-Monofeya,
Egypt.3.5.2. Analysis of spiked plasma samples
The high sensitivity attained by the proposed methods allows
the determination of AMD, in biological ﬂuids. The method
was used to determine the amount of AMD in a healthy male
12 h after an intake of one capsule of AMD, which contains
100 mg AMD. AMD was detected and the results were sum-
marized in Table 3.
4. Conclusions
The redox reaction of AMD using Fe3+ has been investigated.
The formation of Fe2+-phen and Fe2+-bipy complexes were
utilized in the development of simple, accurate, sensitive with
good precision and accuracy spectrophotometric methods A
and B for the analysis of AMD in pure form as well as in dos-
age and biological forms. With these methods, one can do the
analysis at low cost without losing accuracy. The proposed
methods can be used as alternative methods to the ofﬁcial ones
for the routine determination of capsules. This encourages
their successful use in routine analysis of AMD in quality con-
trol laboratories and they involve very simple procedures.
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